• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者的循环免疫复合物、抗铜绿假单胞菌抗体及肺部状况

Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.

作者信息

Lagacé J, Mercier J, Fréchette M, Fournier D, Dubreuil M, Lamarre A, Lapointe J R, Montplaisir S

机构信息

Department of Microbiology and Immunology, Université de Montréal, Quebec, Canada.

出版信息

J Clin Lab Immunol. 1989 Sep;30(1):7-11.

PMID:2534928
Abstract

Serum samples from 37 patients with cystic fibrosis (CF), whose lungs were colonized by Pseudomonas aeruginosa, were tested in a 1 yr prospective study to examine a possible relationship between levels of circulating immune complexes (CIC) and the following parameters: level of specific antibodies to P. aeruginosa; relative importance of P. aeruginosa mucoid and non-mucoid strains isolated from sputum; the forced expiratory volume (FEV1; percentage predicted); the chest X-Ray score (Brasfield system) and the clinical score (Shwachman system). Reactivity of CIC against P. aeruginosa, Staphylococcus aureus, Haemophilus influenzae and Escherichia coli antigens were also assayed. We found that the FEV1, the chest X-Ray and the clinical scores were significantly lower in patients with high levels of CIC than in those with normal levels of CIC (p less than 0.001 for each). We also found that the level of IgG antibodies against P. aeruginosa was significantly higher (p less than 0.001) in patients with high levels of CIC than in those with normal levels of CIC. 78% of patients with high levels of CIC had predominantly mucoid P. aeruginosa isolates whereas only 21% of patients with normal levels of CIC had also predominantly mucoid P. aeruginosa isolates. Specific antibodies to P. aeruginosa were detected in all CIC isolated by polyethylene glycol precipitations from CF patients exhibiting both high levels of CIC and inferior pulmonary status. Our findings support the hypothesis that a high level of CIC in association with an aggressive humoral response to P. aeruginosa correlates with defective pulmonary status in cystic fibrosis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项为期1年的前瞻性研究中,对37例肺部被铜绿假单胞菌定植的囊性纤维化(CF)患者的血清样本进行了检测,以研究循环免疫复合物(CIC)水平与以下参数之间的可能关系:抗铜绿假单胞菌特异性抗体水平;从痰液中分离出的铜绿假单胞菌黏液型和非黏液型菌株的相对重要性;用力呼气量(FEV1;预测百分比);胸部X线评分(布拉斯菲尔德系统)和临床评分(施瓦克曼系统)。还检测了CIC对铜绿假单胞菌、金黄色葡萄球菌、流感嗜血杆菌和大肠杆菌抗原的反应性。我们发现,CIC水平高的患者的FEV1、胸部X线和临床评分显著低于CIC水平正常的患者(每项p均小于0.001)。我们还发现,CIC水平高的患者抗铜绿假单胞菌IgG抗体水平显著高于CIC水平正常的患者(p小于0.001)。CIC水平高的患者中78%主要分离出黏液型铜绿假单胞菌,而CIC水平正常的患者中只有21%也主要分离出黏液型铜绿假单胞菌。在从CIC水平高且肺部状况较差的CF患者中通过聚乙二醇沉淀分离出的所有CIC中均检测到抗铜绿假单胞菌特异性抗体。我们的研究结果支持以下假设:CIC水平高与对铜绿假单胞菌的强烈体液反应相关,这与囊性纤维化患者肺部状况不佳有关。(摘要截短于250字)

相似文献

1
Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.囊性纤维化患者的循环免疫复合物、抗铜绿假单胞菌抗体及肺部状况
J Clin Lab Immunol. 1989 Sep;30(1):7-11.
2
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.囊性纤维化和慢性肺部感染患者中的铜绿假单胞菌染色体β-内酰胺酶。抗生素耐药机制及体液免疫反应靶点。
APMIS Suppl. 2003(116):1-47.
3
Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.循环免疫复合物和铜绿假单胞菌特异性抗体在囊性纤维化中的预后意义
J Clin Lab Immunol. 1987 May;23(1):25-30.
4
Isolation and characterization of circulating immune complexes in cystic fibrosis.囊性纤维化中循环免疫复合物的分离与鉴定
Clin Exp Immunol. 1982 Feb;47(2):301-8.
5
[Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].[患有和未患有铜绿假单胞菌定植的囊性纤维化患者体内的抗铜绿假单胞菌抗体、循环免疫复合物及中性粒细胞抗细胞质抗体]
Pediatr Med Chir. 2001 Jan-Feb;23(1):27-30.
6
IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.囊性纤维化患者痰液和血清中针对铜绿假单胞菌表面抗原的IgA和IgG抗体
Acta Pathol Microbiol Scand C. 1979 Jun;87C(3):229-33.
7
Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.脂多糖(LPS)、LPS免疫复合物和细胞因子作为囊性纤维化和慢性铜绿假单胞菌肺部感染患者肺部炎症的诱导剂。
APMIS Suppl. 1995;50:1-30.
8
Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.用来自铜绿假单胞菌囊性纤维化分离株的黏液样胞外多糖免疫的兔子中,非特异性免疫球蛋白合成及IgG水平升高。
J Immunol. 1984 Aug;133(2):734-9.
9
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.老年未感染铜绿假单胞菌的囊性纤维化患者体内针对铜绿假单胞菌黏液性胞外多糖的调理吞噬杀伤抗体
N Engl J Med. 1987 Sep 24;317(13):793-8. doi: 10.1056/NEJM198709243171303.
10
Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.囊性纤维化中的铜绿假单胞菌感染。正常个体和囊性纤维化患者的血清对来自囊性纤维化患者或其他疾病患者的铜绿假单胞菌菌株的杀菌作用。
Acta Pathol Microbiol Scand C. 1977 Apr;85(2):107-14.

引用本文的文献

1
in chronic lung disease: untangling the dysregulated host immune response.在慢性肺部疾病中:理清失调的宿主免疫反应。
Front Immunol. 2024 Jun 28;15:1405376. doi: 10.3389/fimmu.2024.1405376. eCollection 2024.
2
In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa.黏液型铜绿假单胞菌支气管肺部感染期间小鼠的体外和体内T细胞应答
Clin Exp Immunol. 1995 Jan;99(1):98-105. doi: 10.1111/j.1365-2249.1995.tb03478.x.
3
Four epitopes of Pseudomonas aeruginosa elastase defined by monoclonal antibodies.
由单克隆抗体确定的铜绿假单胞菌弹性蛋白酶的四个表位。
Infect Immun. 1991 Feb;59(2):712-5. doi: 10.1128/iai.59.2.712-715.1991.